4.8 Article

Ventricular Phosphodiesterase-5 Expression Is Increased in Patients With Advanced Heart Failure and Contributes to Adverse Ventricular Remodeling After Myocardial Infarction in Mice

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure

Gregg C. Fonarow et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)

Article Physiology

Parameters of ventricular contractility in mice: influence of load and sensitivity to changes in inotropic state

An Van den Bergh et al.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2008)

Review Cardiac & Cardiovascular Systems

Phosphodiesterase type 5 - Expanding roles in cardiovascular regulation

David A. Kass et al.

CIRCULATION RESEARCH (2007)

Review Cardiac & Cardiovascular Systems

Phosphodiesterase regulation of nitric oxide signaling

David A. Kass et al.

CARDIOVASCULAR RESEARCH (2007)

Article Cardiac & Cardiovascular Systems

Compartmentalization of cardiac β-adrenergic inotropy modulation by phosphodiesterase type 5

Eiki Takimoto et al.

CIRCULATION (2007)

Review Cardiac & Cardiovascular Systems

Overview of PDEs and their regulation

Kenji Omori et al.

CIRCULATION RESEARCH (2007)

Article Cardiac & Cardiovascular Systems

Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure

Gregory D. Lewis et al.

CIRCULATION (2007)

Review Biochemistry & Molecular Biology

Cardiovascular cGMP-generating systems in physiological and pathological conditions

M. C. Cerra et al.

CURRENT MEDICINAL CHEMISTRY (2007)

Review Cardiac & Cardiovascular Systems

Compartmentation of cyclic nucleotide signaling in the heart - The role of cyclic nucleotide phosphodiesterases

Rodolphe Fischmeister et al.

CIRCULATION RESEARCH (2006)

Article Cardiac & Cardiovascular Systems

Sildenafil inhibits β-adrenergic-stimulated cardiac contractility in humans

BA Borlaug et al.

CIRCULATION (2005)

Article Biochemistry & Molecular Biology

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

E Takimoto et al.

NATURE MEDICINE (2005)

Article Cardiac & Cardiovascular Systems

cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism

E Takimoto et al.

CIRCULATION RESEARCH (2005)

Review Cardiac & Cardiovascular Systems

Regulation of nitric oxide-sensitive guanylyl cyclase

A Friebe et al.

CIRCULATION RESEARCH (2003)

Article Biochemistry & Molecular Biology

Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells

SD Rybalkin et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Review Cell Biology

Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases

J Tremblay et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)